Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0164 EUR | +2,50% | -19,61% | -73,20% |
11/04 | BioSenic dient herstructureringsplan in | AM |
20/03 | BioSenic presenteert succesvolle studiedata op het Systemic Sclerosis World Congress 2024 | AM |
Omzet 2023 * | - | Omzet 2024 * | - | Marktkapitalisatie | 2,94 mln. 3,15 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | -5 mln. -5,36 mln. | Nettowinst (verlies) 2024 * | -11 mln. -11,78 mln. | EV/omzet 2023 * | - |
Nettoschuld 2023 * | 18,8 mln. 20,14 mln. | Nettoschuld 2024 * | 29,3 mln. 31,39 mln. | EV/omzet 2024 * | - |
K/w-verhouding 2023 * |
-0,32
x | K/w-verhouding 2024 * |
-0,18
x | Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 73,22% |
1 dag | +2,50% | ||
1 week | -19,61% | ||
Lopende maand | -25,45% | ||
1 maand | -25,45% | ||
3 maanden | -59,00% | ||
6 maanden | -68,46% | ||
Lopend jaar | -73,20% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Francois Rieger
CEO | Chief Executive Officer | - | - |
Lieven Huysse
CTO | Chief Tech/Sci/R&D Officer | - | 03-04-23 |
Nicco Carole
COO | Chief Operating Officer | - | 18-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | - | |
Director/Board Member | 53 | - | |
Francois Rieger
CEO | Chief Executive Officer | - | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 0,0164 | +2,50% | 90 500 |
24-04-24 | 0,016 | -18,37% | 5 497 888 |
23-04-24 | 0,0196 | -4,85% | 1 075 815 |
22-04-24 | 0,0206 | +5,10% | 1 538 483 |
19-04-24 | 0,0196 | -3,92% | 1 916 470 |
Real Time Euronext Bruxelles, 25 april 2024 om 09:19 uur
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-73,20% | 3,14 mln. | |
+25,61% | 660 mld. | |
+23,08% | 562 mld. | |
-5,24% | 358 mld. | |
+16,49% | 322 mld. | |
+8,28% | 297 mld. | |
+12,98% | 219 mld. | |
-9,37% | 196 mld. | |
+6,94% | 199 mld. | |
-8,75% | 149 mld. |